CEFINTRA (Aspen Pharmacare Australia Pty Ltd)
Product name
CEFINTRA
Date registered
Evaluation commenced
Decision date
Approval time
173 (255 working days)
Active ingredients
cefuroxime sodium
Registration type
EOI
Indication
CEFINTRA is indicated for the antibiotic prophylaxis of postoperative endophthalmitis after cataract surgery (see SECTION 5.1, PHARMACODYNAMIC PROPERTIES).
Consideration should be given to official guidance on the appropriate use of antibacterial agents, including guidance on antibiotic prophylaxis in eye surgery.